A1RG34:BVMF
Argenx Se Bdr
R$180,96
0,00%
(0,00) 1D
29 ກ.ລ., 13 ໂມງ 13 ນາທີ 01 ວິນາທີ GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
໕໔,໖໒ ຕື້
Avg. vol.
໑໑໕,໐໐
Volume
໐,໐໐
52-wk high
R$200,20
52-wk low
R$138,18
Shares outstanding
໖໒,໕໖ ລ້ານ
No. of employees
໒ ພັນ
Mkt. cap
໕໔,໖໒ ຕື້
Avg. vol.
໑໑໕,໐໐
Volume
໐,໐໐
52-wk high
R$200,20
52-wk low
R$138,18
Shares outstanding
໖໒,໕໖ ລ້ານ
No. of employees
໒ ພັນ
News stories
From sources across the web
Barchart.com
·
15 ຊົ່ວໂມງກ່ອນ
The Charts Reveal Significant Price Movement in Forte Biosciences Stock Ahead of Argenx’s Acquisition Announcement
Investing.com
·
2 ມື້ກ່ອນ
Argenx stock price target held at $940 by H.C. Wainwright on acquisition
QuotedData
·
2 ມື້ກ່ອນ
Biotech Growth makes 14-times return on Forte Biosciences accepting $2.2bn bid from Argenx SE
www.marketscreener.com
·
2 ມື້ກ່ອນ
The Biotech Growth Trust PLC - argenx SE to acquire BIOG portfolio company, Forte Biosciences, Inc
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr
AI content may include mistakes. Learn more